Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-22T22:49:44.508Z Has data issue: false hasContentIssue false
  • English
  • Français

Readmissions after Diagnosis of Surgical Site Infection Following Knee and Hip Arthroplasty

Published online by Cambridge University Press:  10 May 2016

Kyle G. Miletic ,
Thomas N. Taylor ,
Emily T. Martin ,
Rahul Vaidya  and
Keith S. Kaye
Kyle G. Miletic*
Affiliation:
Department of Internal Medicine, Division of Infectious Diseases, Wayne State University School of Medicine, Detroit, Michigan
Thomas N. Taylor
Affiliation:
Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan
Emily T. Martin
Affiliation:
Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan
Rahul Vaidya
Affiliation:
Department of Orthopaedic Surgery, Detroit Receiving Hospital, Detroit, Michigan
Keith S. Kaye
Affiliation:
Department of Internal Medicine, Division of Infectious Diseases, Wayne State University School of Medicine, Detroit, Michigan
*
100 East Willis, Suite 80, Detroit, MI 48201 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Context.

Surgical site infection (SSI) after total hip and knee arthroplasty is a common postoperative complication. We sought to determine readmission rates and costs for total hip and knee arthroplasty complicated by SSI.

Design.

The Thomson Reuters MarketScan database was searched for patients who underwent knee or hip arthroplasty in 2007. From these data, patients who received a diagnosis of SSI and were readmitted after diagnosis were identified.

Setting.

A population of 31 to 45 million individuals receiving insurance coverage. Patients who underwent knee or hip arthroplasty who experienced a hospitalization for SSI in the year after surgery were analyzed.

Outcome Measures.

Total readmission rates and costs per readmission at 30, 60, and 90 days and 1 year after diagnosis of SSI.

Results.

Of the 76,289 case patients with hip or knee replacement in 2007, 1,026 (1.3%) had a hospitalization for SSI within the year after surgery. Among these patients, 310 (30.2%) were subsequently rehospitalized in the year after initial hospitalization specifically due to SSI-related issues. These rehospitalizations were associated with a mean hospital stay of 7.4 ± 11.4 days and a median cost of $20,001 (interquartile range [IQR], $14,057-$30,551). A total of 517 subjects had a subsequent “all-cause” hospitalization during the year after SSI. These rehospitalizations were associated with a mean hospital stay of 6.4 ± 10.4 days and a median cost of $19,870 (IQR, $13,913-$29,728).

Conclusions.

Readmissions during the year after SSI diagnosis accounted for 1,072 hospital admissions and cost over $25.5 million. These readmissions are costly and might be a future target for decreased reimbursement.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 2 , February 2014 , pp. 152 - 157
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Kirkland, KB, Briggs, JP, Trivette, SL, Wilkinson, WE, Sexton, DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20(11):725–730.Google Scholar
2. Anderson, DJ, Kaye, KS, Chen, LF, et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multicenter matched outcomes study. PloS ONE 2009;4(12):e8305.Google Scholar
3. Whitehouse, JD, Friedman, ND, Kirkland, KB, Richardson, WJ, Sexton, DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002;23(4):183–189.Google Scholar
4. Hidron, AI, Edwards, JR, Patel, J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29(11):996–1011.Google Scholar
5. Zmistowski, B, Parvizi, J. Identification and treatment of infected total hip arthroplasty. Expert Rev Anti Infect Ther 2012;10(4): 509–518.Google Scholar
6. Vanhegan, IS, Morgan-Jones, R, Barrett, DS, Haddad, FS. Developing a strategy to treat established infection in total knee replacement: a review of the latest evidence and clinical practice. J Bone Joint Surg Br 2012;94(7):875–881.Google Scholar
7. Stone, PW, Glied, SA, McNair, PD, et al. CMS changes in reimbursement for HAIs: setting a research agenda. Medical Care 2010;48(5):433–439.Google Scholar
8. Stulberg, JJ, Delaney, CP, Neuhauser, DV, Aron, DC, Fu, P, Koroukian, SM. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA 2010;303(24):2479–2485.Google Scholar
9. Bozic, KJ, Ward, L, Vail, TP, Maze, M. Bundled payments in total joint arthroplasty: targeting opportunities for quality improvement and cost reduction. Clin Orthop Relat Res 2014;472(1): 188–193.Google Scholar
10. Babkin, Y, Raveh, D, Lifschitz, M, et al. Incidence and risk factors for surgical infection after total knee replacement. Scand J Infect Dis 2007;39(10):890–895.Google Scholar
11. Urquhart, DM, Hanna, FS, Brennan, SL, et al. Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review. J Arthroplast 2010;25(8):1216–1222, e1-e3.Google Scholar
12. Cram, P, Lu, X, Kaboli, PJ, et al. Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991-2008. JAMA 2011;305(15):1560–1567.Google Scholar
13. Wolf, BR, Lu, X, Li, Y, Callaghan, JJ, Cram, P. Adverse outcomes in hip arthroplasty: long-term trends. J Bone Joint Surg Am 2012; 94(14):e1038.Google Scholar
14. Phillips, CB, Barrett, JA, Losina, E, et al. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am 2003;85-A(1):20–26.Google Scholar
15. Mahomed, NN, Barrett, JA, Katz, JN, et al. Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J Bone Joint Surg Am 2003;85-A(1): 27–32.Google Scholar
16. Merrill, C, Elixhauser, A. Hospital Stays Involving Musculoskeletal Procedures, 1997-2005. Rockville, MD: Agency for Healthcare Research and Quality, 2007.Google Scholar
17. Calderwood, MS, Ma, A, Khan, YM, et al. Use of Medicare diagnosis and procedure codes to improve detection of surgical site infections following hip arthroplasty, knee arthroplasty, and vascular surgery. Infect Control Hosp Epidemiol 2012;33(1):40–49.Google Scholar
18. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and FY 2012 rates; hospitals' FTE resident caps for graduate medical education payment, 76 Federal Register 51475 (18 August 2011):51511.Google Scholar
19. Dale, H, Skramm, I, Lower, HL, et al. Infection after primary hip arthroplasty: a comparison of 3 Norwegian health registers. Acta Orthop 2011;82(6):646–654.Google Scholar
20. Kaye, KS, Schmit, K, Pieper, C, et al. The effect of increasing age on the risk of surgical site infection. J Infect Dis 2005;191(7): 1056–1062.Google Scholar
21. Costantino, ME, Frey, B, Hall, B, Painter, P. The influence of a postdischarge intervention on reducing hospital readmissions in a medicare population: population health management, 2013. Popul Health Manag 2013;16(5):310–316.Google Scholar
22. Urban, JA. Cost analysis of surgical site infections. Surg Infect 2006;7(suppl 1):S19–S22.Google Scholar
23. Thompson, KM, Oldenburg, WA, Deschamps, C, Rupp, WC, Smith, CD. Chasing zero: the drive to eliminate surgical site infections. Ann Surg 2011;254(3):430–437.Google Scholar
24. Boltz, MM, Raveh, D, Lifschitz, M, et al. Hospital costs associated with surgical site infections in general and vascular surgery patients. Surgery 2011;150(5):934–942.Google Scholar